Biogen CEO discusses challenges of drug discovery

November 8, 2016
As a JCC Fellow, George Scangos participated in creating the first transgenic mouse

Biogen CEO and former JCC Fellow George Scangos recently spoke about the challenges of drug discovery at Cornell University, where he is the Robert S. Hatfield Fellow in Economic Education. When asked how he focuses on Biogen’s core […]

Read More

After years of service, two BSA members retire in 2016

October 19, 2016
Dr. Losick and Dr. De Camilli are retiring from the JCC Board of Scientific Advisors this year

The Jane Coffin Childs Fund thanks Dr. Losick and Dr. De Camilli for their contributions. HHMI Investigator Richard Losick has served on the Board of Scientific Advisors since 2008. The Maria Moors Cabot Professor of Biology at Harvard […]

Read More

Sickle cell disease therapeutic target identified

October 17, 2016
JCC Fellow Elenoe Crew Smith contributed to in vivo studies

Caption: A sickle-shaped blood cell in front of an unaffected red blood cell. EM Unit, UCL Medical School, Royal Free Campus, Creative Commons license: CC BY-NC-ND 2.0   When Elenoe “Crew” Smith joined Stuart Orkin’s lab at Boston […]

Read More